← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 31, 2001Last known activity
Nov 28, 2025
Timeline
1990s
- Jun 1, 1999
Innovaderm— Founded
Drugs by trial phase (66 distinct, 67 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Indications
Studied for
- Acne Vulgaris
- Apnea
- Arthritis
- Arthritis, Rheumatoid
- Atherosclerosis
- Back Pain
- Chickenpox
- Coronary Artery Disease
- Crohn Disease
- Dermatitis
- Dermatitis, Allergic Contact
- Dermatitis, Atopic
- Dermatitis, Contact
- Eczema
- Epilepsies, Myoclonic
- Erythema
- Herpes Zoster
- Hypersensitivity
- Hypersensitivity, Delayed
- Inflammation
- Keratosis
- Keratosis, Actinic
- Myocardial Ischemia
- Onychomycosis
- Psoriasis
- Pyoderma
- Pyoderma Gangrenosum
- Rosacea
- Sleep Apnea, Obstructive
- Sleep Apnea Syndromes
- Syndrome
Recent trials (50)
- NCT07207070OfficialPhase 3Nov 28, 2025
- NCT06969027OfficialPhase 2Jun 19, 2025
- NCT06868836OfficialPhase 2Mar 28, 2025
- NCT06248229OfficialPhase 4Sep 1, 2024
- NCT06505837OfficialPhase 3Jul 11, 2024
- NCT06283550Lead sponsorPhase 2May 31, 2024
- NCT06283550OfficialPhase 2May 31, 2024
- NCT06261021OfficialPhase 2Apr 19, 2024
- NCT06261021Lead sponsorPhase 2Apr 19, 2024
- NCT06018428CollaboratorPhase 2Aug 28, 2023
- NCT05844618Lead sponsorPhase 4May 9, 2023
- NCT05844618Overall official - principal investigatorPhase 4May 9, 2023
- NCT05637216Overall official - principal investigatorPhase 2Jan 1, 2023
- NCT05613660OfficialN/ADec 10, 2022
- NCT05613660Overall official - principal investigatorN/ADec 10, 2022
Details
- Founded
- Montreal, CA Jun 1, 1999
- Last known activity
- Nov 28, 2025